Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Persisting Endothelial Cell Activation and Hypercoagulability after Recovering from COVID-19: The Roadmap-Post COVID-19 Study

Patrick Van Dreden, Evangelos Terpos, Marianna Politou, Meletios A. Dimopoulos, Matthieu Grusse, Grigorios T. Gerotziafas

Blood (2022) 140 (Supplement 1): 2783–2785.

https://doi.org/10.1182/blood-2022-158978

Published: 2022

Journal Articles

Profile of Perioperative Coagulation in Major Liver Resection for Cancer: A Prospective Observational Study

Patrick Van Dreden, Petros Tzimas, Eleftheria Lefkou, Agathi Karakosta, Stellios Argyron, Evangelia Papapetrou, Despoina Pantazi, Alexandros Tselepis, Panagiota Stratigopoulou, Georgios Glantzounis, Kallirroi Kalantzi, Grigorios T. Gerotziafas

Blood (2022) 140 (Supplement 1): 11205–11207.

https://doi.org/10.1182/blood-2022-158683

Published: 2022

Journal Articles

Sex Hormone Levels, Biomarkers of Hypercoagulability and Endothelial Cell Activation Are Determinants of Severity of COVID-19 in Women and Men. the Roadmap-COVID-19 Prospective Study

Patrick Van Dreden, Salahdin Khelifi Otmane, Grigorios T. Gerotziafas, Matthieu Grusse, Aurélie Rousseau, Lila Louadj, Michele Sabbah

Blood (2022) 140 (Supplement 1): 5649–5650.

https://doi.org/10.1182/blood-2022-168576

Published: 2022

Journal Articles

Impact of LMWH and Specific Factor Xa Inhibitors, Apixaban and Fondaparinux, on Cancer Cell Biology and Procoagulant Properties of Cancer Microenvironment

Huong Chi Mai Tran, Rania Amrane, Elisabeth Mbemba, Michele Sabbah, Ismail Elalamy, Jawed Fareed, Patrick Van Dreden, Grigorios T. Gerotziafas

Blood (2021) 138 (Supplement 1): 2136.

https://doi.org/10.1182/blood-2021-146456

Published: 2021

Journal Articles

Biomarkers of Hypercoagulability and Endothelial Cell Activation in Patients with Severe COVID-19 Admitted at the Intensive Care Unit. the Roadmap-COVID-19 Prospective Observational Study

Patrick Van Dreden, PhD, Guillaume Voiriot, Alexandre Alabbadi, Ismail Elalamy, MD PhD, Loula Papageorgiou, Hélène Cost, Aurélie Rousseau, PhD, Matthieu Turpin, Muriel Fartoukh, Grigorios T. Gerotziafas

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-140275

Published: 2020

Journal Articles

Malignant Clonal Cell Proliferation in Multiple Myeloma and the Hypercoagulable State

Tishya Indran, MBBS, Grigorios T. Gerotziafas, Jawed Fareed, PhD, Andrew Spencer

Blood (2020) 136 (Supplement 1): 23–24.

https://doi.org/10.1182/blood-2020-142781

Published: 2020

Journal Articles

Differences in the Coagulation Profile in Women with Mild and Severe Preeclampsia

Elmina Lefkou, Patrick Van Dreden, PhD, Aurélie Rousseau, PhD, Grigorios T. Gerotziafas

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-137401

Published: 2020

Journal Articles

Profile of Thrombin Generation Assay and Thromboelastometry in Women with Moderate and Severe Preeclampsia. the Roadmap-Preeclampsia Study

Patrick Van Dreden, PhD, Elmina Lefkou, Aurélie Rousseau, PhD, Grigorios T. Gerotziafas

Blood (2020) 136 (Supplement 1): 37–38.

https://doi.org/10.1182/blood-2020-137384

Published: 2020

Journal Articles

Procoagulant Microparticles Derived from Myeloma Plasma Cells Have a Determinant Role in the Hypercoagulable State Associated with Multiple Myeloma. a Modelization in Vitro Study

Loula Papageorgiou, Patrick Van Dreden, PhD, Meletios A. Dimopoulos, MD, Annette Larsen, Mohamad Mohty, MD PhD, Ismail Elalamy, MD PhD, Grigorios T. Gerotziafas

Blood (2019) 134 (Supplement_1): 2425.

https://doi.org/10.1182/blood-2019-124650

Published: 2019

Journal Articles

In Newly Diagnosed Multiple Myeloma Patients, Longer Procoagulant Phospholipid-Dependent Clotting Time, Higher Levels of P-Selectin, D-Dimers and Thrombin Generation Peak Are Associated with Increased Risk of Resistance to Treatment: Results of the Prospective Roadmap-MM Study

Grigorios T. Gerotziafas, Despina Fotiou, BMBS, MA, Patrick Van Dreden, PhD, Theodoros N Sergentanis, Ismail Elalamy, MD PhD, Loula Papageorgiou, Matthieu Grusse, Stella Salta, Theodora Psaltopoulou, Annette Larsen, Evangelos Terpos, MD PhD, Meletios A Dimopoulos, MD

Blood (2018) 132 (Supplement 1): 2014.

https://doi.org/10.1182/blood-2018-99-114871

Published: 2018

Journal Articles

Transmission of Procoagulant Properties to Daughter Generations of Endothelial Cells upon Exposure to Cancer Cell-Derived Microparticles. a New Implication of Cancer Derived Microparticles in the Pathogenesis of Cancer Associated Thrombosis

Rania Amrane, Aurélie Rousseau, PhD, Annette Larsen, Patrick Van Dreden, PhD, Grigorios T. Gerotziafas

Blood (2018) 132 (Supplement 1): 1231.

https://doi.org/10.1182/blood-2018-99-114685

Published: 2018

Journal Articles

Chemoresistant Colorectal Cancer (CRC) Cells Show Increased Invasive Potential Which Is Part Is Mediated By VEGF-Signaling and Can be Attenuated By VEGF-Directed Agents

Thouroude Sandrine, Patrick Van Dreden, PhD, Grigorios T. Gerotziafas, Annette Larsen

Blood (2018) 132 (Supplement 1): 4974.

https://doi.org/10.1182/blood-2018-99-110202

Published: 2018

Journal Articles

External Validation and Revision of Thrombosis Lymphoma /Throly/ Score

Darko Antic, PhD, Natasa Milic, Biljana Mihaljevic, Bruce Cheson, MD, Mayur Narkhede, MD, Hikmat Abdel-Razeq, Irina Panovska, Sanja Trajkova, Marija Popova, Igor Aurer, Ana Boban, Michele Ghielmini, Alden Moccia, Aurelien Delluc, Jean-Christophe Ianotto, Ulrich Jaeger, MD, Cathrin Skrabs, Grigorios T. Gerotziafas, Jawed Fareed, PhD

Blood (2018) 132 (Supplement 1): 140.

https://doi.org/10.1182/blood-2018-99-115568

Published: 2018

Journal Articles

Development and External Validation of Thrombosis Lymphoma /Throly/ Score–Interim Analysis

Darrko Antic, Mihaljevic Biljana, Natasa Milic, Bruce D. Cheson, MD, Mayur Narkhede, MD, Irina Panovska, Sanja Trajkova, Marija Popova, Pilar Llamas, MDPhD, Arantxa Garcías Raso, Aurelien Delluc, MD PhD, Jean-Christophe Ianotto, MD, Grigorios T. Gerotziafas, MD PhD, Jawed Fareed, PhD

Blood (2017) 130 (Supplement 1): 558.

https://doi.org/10.1182/blood.V130.Suppl_1.558.558

Published: 2017

Journal Articles

Defining the Balance between the Expression of Procoagulant, Anticoagulant and Angiogenic Molecules in Myeloma Plasma Cells

Loula Papageorgiou, Sandrine Thouronde, Patrick Van Dreden, PhD, Stella Salta, Laurent Garderet, MD PhD, Christelle Mazurier, Ismail Elalamy, MD PhD, Grigorios T. Gerotziafas, MD PhD

Blood (2017) 130 (Supplement 1): 5364.

https://doi.org/10.1182/blood.V130.Suppl_1.5364.5364

Published: 2017

Journal Articles

Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer Associated Thrombosis. the Observational Roadmap-CAT Study

Grigorios T. Gerotziafas, MD PhD, Patrick Van Dreden, PhD, Stella Salta, Loula Papageorgiou, Paraskevi Boura, Annette Larsen, Jawed Fareed, PhD, Konstantinos Syrigos, Ismail Elalamy, MD PhD

Blood (2017) 130 (Supplement 1): 2381.

https://doi.org/10.1182/blood.V130.Suppl_1.2381.2381

Published: 2017

Journal Articles

Procoagulant Phospholipid Dependent Clotting Time: A New Tool for the Identification of Multiple Myeloma Patients at Risk Poor Treatment Response

Fotiou Despina, Loula Papageorgiou, Stella Salta, Patrick Van Dreden, PhD, Evangelos Terpos, Jawed Fareed, PhD, Matthieu Grusse, Ismail Elalamy, MD PhD, Laurent Garderet, MD PhD, Christelle Mazurier, Grigorios T. Gerotziafas, MD PhD

Blood (2017) 130 (Supplement 1): 1110.

https://doi.org/10.1182/blood.V130.Suppl_1.1110.1110

Published: 2017

Journal Articles

An Ex Vivo Analysis of Thrombin Generation and Thromboelastometry in Patients Undergoing Treatment with Rivaroxaban Demonstrates Sustained Anticoagulant Effect and High Inter-Individual Variability

Stella Salta, Patrick Van Dreden, PhD, Loula Papageorgiou, Jawed Fareed, PhD, Ismail Elalamy, MD PhD, Grigorios T. Gerotziafas, MD PhD

Blood (2017) 130 (Supplement 1): 3722.

https://doi.org/10.1182/blood.V130.Suppl_1.3722.3722

Published: 2017

Journal Articles

Alteration of Endothelial Cell Hemostatic Equilibrium By Cancer Cell-Derived Microparticles, a New Insight in Pathogenesis of Cancer Associated Thrombosis

Aurélie Rousseau, PhD, Rania Amrane, Patrick Van Dreden, PhD, Loula Papageorgiou, Annette Larsen, Amir Khaterchi, Ismail Elalamy, MD PhD, Grigorios T. Gerotziafas, MD PhD

Blood (2017) 130 (Supplement 1): 3698.

https://doi.org/10.1182/blood.V130.Suppl_1.3698.3698

Published: 2017

Journal Articles

A Clinic-Genetic Score for Risk Assessment of Recurrent Venous Thrombo Embolism

Grigorios T. Gerotziafas, MD PhD, Manuella Onambele, L Benzerara, H Mokrani, Hela Ketatni, V Planche, C Delassasseigne, Ismail Elalamy, MDPhD

Blood (2016) 128 (22): 1428.

https://doi.org/10.1182/blood.V128.22.1428.1428

Published: 2016

NARROW

Persisting Endothelial Cell Activation and Hypercoagulability after Recovering from COVID-19: The Roadmap-Post COVID-19 Study

Profile of Perioperative Coagulation in Major Liver Resection for Cancer: A Prospective Observational Study

Sex Hormone Levels, Biomarkers of Hypercoagulability and Endothelial Cell Activation Are Determinants of Severity of COVID-19 in Women and Men. the Roadmap-COVID-19 Prospective Study

Impact of LMWH and Specific Factor Xa Inhibitors, Apixaban and Fondaparinux, on Cancer Cell Biology and Procoagulant Properties of Cancer Microenvironment

Biomarkers of Hypercoagulability and Endothelial Cell Activation in Patients with Severe COVID-19 Admitted at the Intensive Care Unit. the Roadmap-COVID-19 Prospective Observational Study

Malignant Clonal Cell Proliferation in Multiple Myeloma and the Hypercoagulable State

Differences in the Coagulation Profile in Women with Mild and Severe Preeclampsia

Profile of Thrombin Generation Assay and Thromboelastometry in Women with Moderate and Severe Preeclampsia. the Roadmap-Preeclampsia Study

Procoagulant Microparticles Derived from Myeloma Plasma Cells Have a Determinant Role in the Hypercoagulable State Associated with Multiple Myeloma. a Modelization in Vitro Study

In Newly Diagnosed Multiple Myeloma Patients, Longer Procoagulant Phospholipid-Dependent Clotting Time, Higher Levels of P-Selectin, D-Dimers and Thrombin Generation Peak Are Associated with Increased Risk of Resistance to Treatment: Results of the Prospective Roadmap-MM Study

Transmission of Procoagulant Properties to Daughter Generations of Endothelial Cells upon Exposure to Cancer Cell-Derived Microparticles. a New Implication of Cancer Derived Microparticles in the Pathogenesis of Cancer Associated Thrombosis

Chemoresistant Colorectal Cancer (CRC) Cells Show Increased Invasive Potential Which Is Part Is Mediated By VEGF-Signaling and Can be Attenuated By VEGF-Directed Agents

External Validation and Revision of Thrombosis Lymphoma /Throly/ Score

Development and External Validation of Thrombosis Lymphoma /Throly/ Score–Interim Analysis

Defining the Balance between the Expression of Procoagulant, Anticoagulant and Angiogenic Molecules in Myeloma Plasma Cells

Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer Associated Thrombosis. the Observational Roadmap-CAT Study

Procoagulant Phospholipid Dependent Clotting Time: A New Tool for the Identification of Multiple Myeloma Patients at Risk Poor Treatment Response

An Ex Vivo Analysis of Thrombin Generation and Thromboelastometry in Patients Undergoing Treatment with Rivaroxaban Demonstrates Sustained Anticoagulant Effect and High Inter-Individual Variability

Alteration of Endothelial Cell Hemostatic Equilibrium By Cancer Cell-Derived Microparticles, a New Insight in Pathogenesis of Cancer Associated Thrombosis

A Clinic-Genetic Score for Risk Assessment of Recurrent Venous Thrombo Embolism

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only